Detalhe da pesquisa
1.
A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.
Invest New Drugs
; 33(2): 409-22, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25529193
2.
Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.
Haematologica
; 100(7): 955-63, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25911553
3.
Sentinel node biopsy after primary chemotherapy in breast cancer: a note of caution from results of ABCSG-14.
Breast J
; 17(3): 230-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21450019
4.
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Ann Hematol
; 89(3): 273-82, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19693500
5.
6.
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Anticancer Res
; 37(10): 5553-5558, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28982869
7.
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Eur J Cancer
; 58: 112-21, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26990931
8.
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.
Anticancer Res
; 35(1): 517-21, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25550597
9.
Is the statistical difference clinically relevant?
J Clin Oncol
; 23(33): 8537; author reply 8537-8, 2005 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16293884
10.
Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).
Anticancer Res
; 31(12): 4439-43, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22199312
11.
Long-term results of dose density therapy in patients with aggressive lymphoma.
Ann Hematol
; 84(4): 217-22, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15538568